- Recommendation ID
- NG230/05
- Question
Radioactive iodine: What is the clinical and cost effectiveness of RAI after total or completion thyroidectomy for people with T2 disease and no adverse pathological features?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on RAI for initial ablation.
Full details of the evidence and the committee's discussion are in evidence review J: radioactive iodine versus no radioactive iodine.
Source guidance details
- Comes from guidance
- Thyroid cancer: assessment and management
- Number
- NG230
- Date issued
- December 2022
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/12/2022 |